{"id":"W3137607562","doi":"10.1016/j.ekir.2021.02.041","title":"Invasive Management of Coronary Artery Disease in Advanced Renal Disease","year":2021,"lang":"en","type":"review","venue":"Kidney International Reports","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Data Science Institute, Columbia University; Canada Excellence Research Chairs, Government of Canada; Janssen Scientific Affairs; Idorsia Pharmaceuticals; Siemens Medical Solutions USA; Boston Scientific Corporation; National Institute of Allergy and Infectious Diseases; OrbusNeich; Bayer; American Medical Association; Chiesi Farmaceutici; Bristol-Myers Squibb; AstraZeneca; CSL Behring; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Gilead Sciences; Medtronic; Abbott Vascular; Abbott Laboratories","keywords":"Medicine; Kidney disease; Coronary artery disease; Intensive care medicine; Disease; Population; Renal function; Randomized controlled trial; Internal medicine; Epidemiology; Cardiology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001065466,0.0007413102,0.002004026,0.00208989,0.0002471721,0.0009493527,0.000881764,0.001067923,0.003779023],"category_scores_gemma":[0.002133643,0.000223495,0.001356944,0.001688319,0.0003564619,0.0008211288,0.0006001464,0.001393833,0.000795736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004842288,"about_ca_system_score_gemma":0.001362161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001227579,"about_ca_topic_score_gemma":0.002418388,"domain_scores_codex":[0.9995257,0.0001369427,0.0001102923,0.00005865667,0.0001375042,0.00003088547],"domain_scores_gemma":[0.9991758,0.0005809112,0.0001108391,0.00001700635,0.00009196168,0.00002341297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001338703,0.00006140427,0.0002190827,0.09737266,0.0004705733,0.0001109616,0.00006839573,0.0002163957,0.0004069064,0.001879611,0.0171569,0.8819032],"study_design_scores_gemma":[0.0001873997,0.0003035204,0.004563887,0.1222066,0.002277278,0.002696386,0.0001695865,0.0002131742,0.0004160625,0.003225867,0.8636954,0.00004481612],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006212758,0.999384,0.00003842404,0.0001108045,0.00009990132,0.000005992461,0.00001012289,0.000002074547,0.0002865245],"genre_scores_gemma":[0.0005043682,0.9990509,0.0001041237,0.0001345357,0.00008341111,0.000007918165,0.00001770174,6.450719e-7,0.00009645868],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003779023,"threshold_uncertainty_score":0.01264209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02401121940761898,"score_gpt":0.3285877433993404,"score_spread":0.3045765239917214,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}